Low cell motility induced by hsp27 overexpression decreases osteolytic bone metastases of human breast cancer cells in vivo

Pierre Lemieux, J. Harvey, Theresa Guise, Mark Dallas, Steffi Oesterreich, Juan Juan Yin, Katri Selander, Suzanne Fuqua

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The mechanisms controlling the formation of osteolytic bone metastases in patients with breast cancer are still poorly understood. To explore the role of motility in the establishment of osteolytic bone metastases, we have used a model of bone metastasis in which MDA-MB-231 breast cancer cells exhibiting low (hsp27-transfectants) and high (control-transfectant) endogenous cell motility were compared. We found that MDA-MB-231 cells exhibiting low cell motility were less capable of establishing osteolytic lesions. The number and the area of the osteolytic lesions in mice inoculated with low motility cells were both significantly smaller. Histomorphometry of bone lesions also demonstrated less tumor area in mice bearing hsp27 transfectants although there was no difference in the osteoclast number per square millimeter of tumor-bone interface. These data suggest that cell motility may be an important mechanism in the metastatic cascade of breast cancer cells to the bone and that controlling cell motility may be a useful target to prevent the establishment of osteolytic bone metastases.

Original languageEnglish (US)
Pages (from-to)1570-1575
Number of pages6
JournalJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Volume14
Issue number9
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Cell Movement
Breast Neoplasms
Neoplasm Metastasis
Bone and Bones
Osteoclasts
Osteogenesis
Neoplasms

ASJC Scopus subject areas

  • Surgery

Cite this

Low cell motility induced by hsp27 overexpression decreases osteolytic bone metastases of human breast cancer cells in vivo. / Lemieux, Pierre; Harvey, J.; Guise, Theresa; Dallas, Mark; Oesterreich, Steffi; Yin, Juan Juan; Selander, Katri; Fuqua, Suzanne.

In: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, Vol. 14, No. 9, 1999, p. 1570-1575.

Research output: Contribution to journalArticle

@article{ede93ca6c67746f0898720cc2772d1f4,
title = "Low cell motility induced by hsp27 overexpression decreases osteolytic bone metastases of human breast cancer cells in vivo",
abstract = "The mechanisms controlling the formation of osteolytic bone metastases in patients with breast cancer are still poorly understood. To explore the role of motility in the establishment of osteolytic bone metastases, we have used a model of bone metastasis in which MDA-MB-231 breast cancer cells exhibiting low (hsp27-transfectants) and high (control-transfectant) endogenous cell motility were compared. We found that MDA-MB-231 cells exhibiting low cell motility were less capable of establishing osteolytic lesions. The number and the area of the osteolytic lesions in mice inoculated with low motility cells were both significantly smaller. Histomorphometry of bone lesions also demonstrated less tumor area in mice bearing hsp27 transfectants although there was no difference in the osteoclast number per square millimeter of tumor-bone interface. These data suggest that cell motility may be an important mechanism in the metastatic cascade of breast cancer cells to the bone and that controlling cell motility may be a useful target to prevent the establishment of osteolytic bone metastases.",
author = "Pierre Lemieux and J. Harvey and Theresa Guise and Mark Dallas and Steffi Oesterreich and Yin, {Juan Juan} and Katri Selander and Suzanne Fuqua",
year = "1999",
doi = "10.1359/jbmr.1999.14.9.1570",
language = "English (US)",
volume = "14",
pages = "1570--1575",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Low cell motility induced by hsp27 overexpression decreases osteolytic bone metastases of human breast cancer cells in vivo

AU - Lemieux, Pierre

AU - Harvey, J.

AU - Guise, Theresa

AU - Dallas, Mark

AU - Oesterreich, Steffi

AU - Yin, Juan Juan

AU - Selander, Katri

AU - Fuqua, Suzanne

PY - 1999

Y1 - 1999

N2 - The mechanisms controlling the formation of osteolytic bone metastases in patients with breast cancer are still poorly understood. To explore the role of motility in the establishment of osteolytic bone metastases, we have used a model of bone metastasis in which MDA-MB-231 breast cancer cells exhibiting low (hsp27-transfectants) and high (control-transfectant) endogenous cell motility were compared. We found that MDA-MB-231 cells exhibiting low cell motility were less capable of establishing osteolytic lesions. The number and the area of the osteolytic lesions in mice inoculated with low motility cells were both significantly smaller. Histomorphometry of bone lesions also demonstrated less tumor area in mice bearing hsp27 transfectants although there was no difference in the osteoclast number per square millimeter of tumor-bone interface. These data suggest that cell motility may be an important mechanism in the metastatic cascade of breast cancer cells to the bone and that controlling cell motility may be a useful target to prevent the establishment of osteolytic bone metastases.

AB - The mechanisms controlling the formation of osteolytic bone metastases in patients with breast cancer are still poorly understood. To explore the role of motility in the establishment of osteolytic bone metastases, we have used a model of bone metastasis in which MDA-MB-231 breast cancer cells exhibiting low (hsp27-transfectants) and high (control-transfectant) endogenous cell motility were compared. We found that MDA-MB-231 cells exhibiting low cell motility were less capable of establishing osteolytic lesions. The number and the area of the osteolytic lesions in mice inoculated with low motility cells were both significantly smaller. Histomorphometry of bone lesions also demonstrated less tumor area in mice bearing hsp27 transfectants although there was no difference in the osteoclast number per square millimeter of tumor-bone interface. These data suggest that cell motility may be an important mechanism in the metastatic cascade of breast cancer cells to the bone and that controlling cell motility may be a useful target to prevent the establishment of osteolytic bone metastases.

UR - http://www.scopus.com/inward/record.url?scp=0032833144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032833144&partnerID=8YFLogxK

U2 - 10.1359/jbmr.1999.14.9.1570

DO - 10.1359/jbmr.1999.14.9.1570

M3 - Article

VL - 14

SP - 1570

EP - 1575

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 9

ER -